Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis

Company Overview

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation. These offerings are supported by proprietary technologies in flow, temperature and humidity control that aim to improve patient comfort and clinical efficacy.

Incorporated as a standalone entity in 2001, Fisher & Paykel Healthcare traces its roots to the Fisher & Paykel Appliances business, leveraging decades of engineering expertise and a long-standing commitment to research and development. Over time, the company has built a track record of clinical studies and product innovations that address evolving needs in respiratory therapy and neonatal care.

Fisher & Paykel Healthcare serves hospitals, clinics and homecare providers in more than 120 countries. It maintains manufacturing facilities, research centres and regional sales offices across Asia Pacific, North America and Europe, enabling close collaboration with healthcare professionals and rapid response to market requirements.

Key Stats

• Today's Range: $20.55 to $20.55
• 50-Day Range: $20.55 to $23.02
• 52-Week Range: $16.35 to $25.69
• Volume: N/A
• Average Volume: 2,831 shs
• Market Capitalization: N/A
• P/E Ratio: 121.14
• Dividend Yield: 0.32%
• Price Target: N/A
• Consensus Rating: Hold

Fisher & Paykel Healthcare Stock Analysis - MarketRank™

Fisher & Paykel Healthcare scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Fisher & Paykel Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Fisher & Paykel Healthcare has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Fisher & Paykel Healthcare is 121.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fisher & Paykel Healthcare is 121.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.01.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 9.02.

Change versus previous month

Short interest in Fisher & Paykel Healthcare has recently decreased by 5.97%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Fisher & Paykel Healthcare pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fisher & Paykel Healthcare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fisher & Paykel Healthcare is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fisher & Paykel Healthcare insiders have not sold or bought any company stock.

Percentage Held by Institutions

31.42% of the stock of Fisher & Paykel Healthcare is held by institutions.

Company Calendar

• Today: 5/25/2026
• Next Earnings (Estimated): 5/25/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:FSPKF
• CIK: N/A
• Web: www.fphcare.com
• Phone: (649) 574-0100
• Fax: N/A
• Employees: 6,391
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 121.14
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A